45
Participants
Start Date
July 31, 2013
Primary Completion Date
January 31, 2019
Study Completion Date
January 31, 2019
NI-0501
Istituto Giannina Gaslini, Genoa
Karolinska University Hospital, Stockholm
Alfred I. duPont Hospital for Children - Nemours Center for Cancer and Blood Disorders - Division of Pediatric Hematology Oncology, Wilmington
Azienda Ospedaliera San Gerardo, Monza
University of North Carolina at Chapel Hill, Chapel Hill
Hospital Universitario Niño Jesús, Madrid
Children's Healthcare of Atlanta, Atlanta
Azienda Ospedaliera Padova - Clinica di Oncoematologia Pediatrica, Padua
Ospedale Donna Bambino - U.O.C. Oncoematologia Pediatrica, Verona
University Children's Hospital, Münster
Azienda Ospedaliero Universitaria Meyer, Florence
Texas Children's Cancer Center, Houston
Primary Children's Hospital, Salt Lake City
Children's Hospital Colorado, Aurora
Dana-Farber Cancer Institute (DFCI), Boston
Cincinnati Children's Hospital - Division of Immunobiology - Department of Pediatrics, Cincinnati
Ospedale Pediatrico Bambino Gesu', Roma
Hospital Sant Joan de Déu, Barcelona
Hospital Universitario Vall d'Hebron, Barcelona
Great Ormond Street Hospital - Department of Haematology, London
Lead Sponsor
Seventh Framework Programme
OTHER
Swedish Orphan Biovitrum
INDUSTRY